Proteasomal adaptations underlying carfilzomib‐resistance in human bone marrow plasma cells
暂无分享,去创建一个
P. Kloetzel | B. Aronow | Harinder Singh | E. Woodle | R. Alloway | E. Woodle | S. Tremblay | J. Driscoll | A. Girnita | K. Kim | Nupur Dasgupta | F. Ebstein | Min Jae Lee | P. Brailey | Min-Jae Lee
[1] S. Fishbane,et al. Opportunities for Increasing the Rate of Preemptive Kidney Transplantation. , 2018, American Society of Nephrology. Clinical Journal.
[2] D. Segev,et al. Antibody‐mediated rejection: New approaches in prevention and management , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] S. Jordan,et al. Desensitization: Overcoming the Immunologic Barriers to Transplantation , 2017, Journal of immunology research.
[4] Lei Shi,et al. Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in mice , 2016, Proceedings of the National Academy of Sciences.
[5] A. Palumbo,et al. Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. , 2016, The New England journal of medicine.
[6] W. Baldwin,et al. Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts , 2016, Current opinion in organ transplantation.
[7] E. Johansson,et al. Interaction of Proteasomes and Complement C3, Assay of Antisecretory Factor in Blood , 2016, Journal of immunoassay & immunochemistry.
[8] E. Remmers,et al. Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production. , 2015, The Journal of clinical investigation.
[9] R. Korngold,et al. Inhibition of the Immunoproteasome Subunit LMP7 with ONX 0914 Ameliorates Graft-versus-Host Disease in an MHC-Matched Minor Histocompatibility Antigen-Disparate Murine Model. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[10] Aspire Investigators,et al. Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma , 2015 .
[11] R. Alloway,et al. Prospective Iterative Trial of Proteasome Inhibitor‐Based Desensitization , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[12] K. Tarte,et al. IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors , 2014, Leukemia.
[13] P S Heeger,et al. Comprehensive Assessment and Standardization of Solid Phase Multiplex‐Bead Arrays for the Detection of Antibodies to HLA , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] C. Drachenberg,et al. Pancreas transplantation, antibodies and rejection: where do we stand? , 2013, Current opinion in organ transplantation.
[15] M. Care,et al. In Vitro Generation of Long-lived Human Plasma Cells , 2012, The Journal of Immunology.
[16] P. Cascio,et al. Pivotal Advance: Protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitors , 2012, Journal of leukocyte biology.
[17] K. Arima,et al. Prophylactic and therapeutic efficacies of a selective inhibitor of the immunoproteasome for Hashimoto's thyroiditis, but not for Graves' hyperthyroidism, in mice , 2012, Clinical and experimental immunology.
[18] P. Kloetzel,et al. Emerging roles of immunoproteasomes beyond MHC class I antigen processing , 2012, Cellular and Molecular Life Sciences.
[19] R. Tooze,et al. In Vitro Generation of “Long-Lived” Human Plasma Cells , 2011 .
[20] D. Standley,et al. A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. , 2011, The Journal of clinical investigation.
[21] N. Niikawa,et al. Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome , 2011, Proceedings of the National Academy of Sciences.
[22] E. Woodle,et al. Early and Late Acute Antibody-Mediated Rejection Differ Immunologically and in Response to Proteasome Inhibition , 2011, Transplantation.
[23] J. Coresh,et al. Trends in the timing of pre-emptive kidney transplantation. , 2011, Journal of the American Society of Nephrology : JASN.
[24] M. Stegall,et al. The Impact of Proteasome Inhibition on Alloantibody-Producing Plasma Cells In Vivo , 2011, Transplantation.
[25] A. Garg,et al. PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. , 2010, American journal of human genetics.
[26] K. Kitamoto,et al. Desensitization protocol in highly HLA-sensitized and ABO-incompatible high titer kidney transplantation. , 2010, Transplantation proceedings.
[27] M. Groettrup,et al. Prevention of Experimental Colitis by a Selective Inhibitor of the Immunoproteasome , 2010, The Journal of Immunology.
[28] A. Paller,et al. Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. , 2010, Journal of the American Academy of Dermatology.
[29] M. Jourdan,et al. An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization. , 2009, Blood.
[30] Khalid W. Kalim,et al. A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis , 2009, Nature Medicine.
[31] D. Finley,et al. Recognition and processing of ubiquitin-protein conjugates by the proteasome. , 2009, Annual review of biochemistry.
[32] T. Riss,et al. Cell-based bioluminescent assays for all three proteasome activities in a homogeneous format. , 2009, Analytical biochemistry.
[33] R. Alloway,et al. Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection , 2008, Transplantation.
[34] M. Stegall,et al. Proteasome Inhibition Causes Apoptosis of Normal Human Plasma Cells Preventing Alloantibody Production , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[35] S. Jordan,et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. , 2008, The New England journal of medicine.
[36] Alan B Leichtman,et al. Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[37] K. Fairfax,et al. Plasma cell development: from B-cell subsets to long-term survival niches. , 2008, Seminars in immunology.
[38] M. Stegall,et al. The Effect of Desensitization Protocols on Human Splenic B‐Cell Populations In Vivo , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[39] M. Fishbein,et al. Acute antibody-mediated rejection of cardiac transplants. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[40] Hartmut Goldschmidt,et al. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. , 2005, The New England journal of medicine.
[41] K. Anderson,et al. Proteasome inhibitor therapy in multiple myeloma , 2005, Molecular Cancer Therapeutics.
[42] A. Chan,et al. Pathogenic roles of B cells in human autoimmunity; insights from the clinic. , 2004, Immunity.
[43] G. Underhill,et al. The Role of Bone Marrow-Derived Stromal Cells in the Maintenance of Plasma Cell Longevity1 , 2002, The Journal of Immunology.
[44] P. Kloetzel,et al. Ubiquitin and proteasomes: Antigen processing by the proteasome , 2001, Nature Reviews Molecular Cell Biology.
[45] L. Matarán,et al. Association of large molecular weight proteasome 7 gene polymorphism with ankylosing spondylitis. , 1998, Arthritis and rheumatism.
[46] R. Ahmed,et al. Long‐Term Antibody Production Is Sustained by Antibody‐Secreting Cells in the Bone Marrow following Acute Viral Infection a , 1996, Annals of the New York Academy of Sciences.
[47] N. Maclaren,et al. Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies. , 1995, American journal of human genetics.
[48] H. Bohorquez,et al. Antibody-Mediated Rejection: A Review. , 2017, The Ochsner journal.
[49] Michael L. Wang,et al. Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma. , 2015, The New England journal of medicine.
[50] S. Elsasser,et al. Characterization of the proteasome using native gel electrophoresis. , 2005, Methods in enzymology.